Everest Organics Limited is a pharmaceutical company. The Company is engaged in the business of bulk drugs and active pharmaceutical ingredients (APIs). It is involved in manufacturing of bulk drugs, such as Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen and Benzimadizole. Its products under APIs include Pantoprazole Sodium Sesquihydrate-USP/BP/EP/IP; Esomeprazole Magnesium Trihydrate-USP/BP/IP/EP; Esomeprazole Magnesium Trihydrate- USP/BP (Non-infringing route); Esomeprazole Magnesium Dihydrate; Omeprazole Powder-USP/ BP/EP/IP; Omeprazole Magnesium-IP/EP/USP, and Esomeprazole Sodium. Its intermediates include 2-Mercapto-5-Methoxy Benzimidazole (Omeprazole-Benzimidazole); 2-chloro-methyl-3, 5-dimethyl-4-methoxy pyridine HCL (Omeprazole Chloro Compound); Sodium Nitrite; Ammonium Sulphate, and Trisodium Orthophosphate (TSP). Its products under development includes Vildagliptin, Ilaprazole, Esomeprazole Magnesium Dihydrate, Lanso Chloro Compound and Lanso Sulphide.